BioCatalystWatch
REVBWorkspace / REVB / OverviewCompany library
REVELATION BIOSCIENCES, INC. logo

REVELATION BIOSCIENCES, INC.

REVELATION BIOSCIENCES, INC. (REVB)

Website

Price
Market cap
Next catalystExpected Q4 2026GEM-AKI · Trial initiationCompany presentation ↗
Cash

Chart & Events

Candle interval

Core Clinical

GEM-AKI

TLR4

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

GEM-AKI

TLR4

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

GEM-AKI

TLR4

PreINDP1P2P3FilingApproved
GEM-AKI

TLR4

PreINDP1P2P3FilingApproved
GEM-CKD

PreINDP1P2P3FilingApproved
Gemini

TLR4

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

History / paused

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

REVB PR & News

PR & News

REVB SEC archive